Annual Reports

 
Quarterly Reports

  • 10-Q (May 8, 2013)
  • 10-Q (Nov 8, 2012)
  • 10-Q (Aug 8, 2012)
  • 10-Q (May 9, 2012)
  • 10-Q (Nov 3, 2011)
  • 10-Q (Aug 4, 2011)

 
8-K

 
Other

KKR Financial 10-Q 2011

Documents found in this filing:

  1. 10-Q
  2. Ex-10.18
  3. Ex-31.1
  4. Ex-31.2
  5. Ex-32
  6. Graphic
  7. Graphic

Table of Contents

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 

(Mark One)

 

x      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2011

 

or

 

o         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission file number: 001-33437

 


 

KKR FINANCIAL HOLDINGS LLC

(Exact name of registrant as specified in its charter)

 

Delaware
(State or other jurisdiction of
incorporation or organization)

 

11-3801844
(I.R.S. Employer
Identification No.)

 

 

 

555 California Street, 50th Floor
San Francisco, CA

(Address of principal executive offices)

 

94104
(Zip Code)

 

Registrant’s telephone number, including area code: (415) 315-3620

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x Yes  o No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x  No o

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer x

 

Accelerated filer o

 

 

 

Non-accelerated filer o
(Do not check if a smaller reporting company)

 

Smaller reporting company o

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). o Yes  x No

 

The number of shares of the registrant’s common shares outstanding as of April 25, 2011 was 178,127,870.

 

 

 




Table of Contents

 

PART I.    FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

KKR Financial Holdings LLC and Subsidiaries

Condensed Consolidated Balance Sheets

(Unaudited)

(Amounts in thousands, except share information)

 

 

 

March 31,
2011

 

December 31,
2010

 

Assets

 

 

 

 

 

Cash and cash equivalents

 

$

129,332

 

$

313,829

 

Restricted cash and cash equivalents

 

591,580

 

571,425

 

Securities available-for-sale, $745,232 and $728,558 pledged as collateral as of March 31, 2011 and December 31, 2010, respectively

 

846,676

 

838,894

 

Corporate loans, net of allowance for loan losses of $198,582 and $209,030 as of March 31, 2011 and December 31, 2010, respectively

 

5,632,057

 

5,857,816

 

Corporate loans held for sale

 

869,808

 

463,628

 

Residential mortgage-backed securities, at estimated fair value

 

90,369

 

93,929

 

Equity investments, at estimated fair value, $15,824 and $12,036 pledged as collateral as of March 31, 2011 and December 31, 2010, respectively

 

147,462

 

99,955

 

Derivative assets

 

23,921

 

19,519

 

Interest and principal receivable

 

45,898

 

57,414

 

Other assets

 

153,835

 

102,003

 

Total assets

 

$

8,530,938

 

$

8,418,412

 

Liabilities

 

 

 

 

 

Collateralized loan obligation secured debt

 

$

5,646,037

 

$

5,630,272

 

Collateralized loan obligation junior secured notes to affiliates

 

365,848

 

366,124

 

Credit facilities

 

18,400

 

18,400

 

Convertible senior notes

 

344,428

 

344,142

 

Junior subordinated notes

 

283,517

 

283,517

 

Accounts payable, accrued expenses and other liabilities

 

23,887

 

14,193

 

Accrued interest payable

 

16,233

 

22,846

 

Accrued interest payable to affiliates

 

7,064

 

6,316

 

Related party payable

 

15,766

 

12,988

 

Derivative liabilities

 

76,733

 

76,566

 

Total liabilities

 

6,797,913

 

6,775,364

 

Shareholders’ Equity

 

 

 

 

 

Preferred shares, no par value, 50,000,000 shares authorized and none issued and outstanding at March 31, 2011 and December 31, 2010

 

 

 

Common shares, no par value, 500,000,000 shares authorized, and 178,127,870 and 177,848,565 shares issued and outstanding at March 31, 2011 and December 31, 2010, respectively

 

 

 

Paid-in-capital

 

2,758,033

 

2,756,200

 

Accumulated other comprehensive income

 

154,692

 

133,596

 

Accumulated deficit

 

(1,179,700

)

(1,246,748

)

Total shareholders’ equity

 

1,733,025

 

1,643,048

 

Total liabilities and shareholders’ equity

 

$

8,530,938

 

$

8,418,412

 

 

See notes to condensed consolidated financial statements.

 

3



Table of Contents

 

KKR Financial Holdings LLC and Subsidiaries

Condensed Consolidated Statements of Operations

(Unaudited)

(Amounts in thousands, except per share information)

 

 

 

For the three
months ended
March 31,
2011

 

For the three
months ended
March 31,
2010

 

Net investment income:

 

 

 

 

 

Loan interest income

 

$

109,645

 

$

91,996

 

Securities interest income

 

22,556

 

27,261

 

Other investment income

 

3,129

 

93

 

Total investment income

 

135,330

 

119,350

 

Interest expense

 

32,121

 

31,500

 

Interest expense to affiliates

 

12,096

 

4,541

 

Provision for loan losses

 

11,661

 

 

Net investment income

 

79,452

 

83,309

 

Other income:

 

 

 

 

 

Net realized and unrealized gain on investments

 

39,184

 

34,667

 

Net realized and unrealized gain (loss) on derivatives and foreign exchange

 

6,067

 

(1,418

)

Net realized and unrealized loss on residential mortgage-backed securities, residential mortgage loans, and residential mortgage-backed securities issued, carried at estimated fair value

 

(738

)

(5,145

)

Net gain on restructuring and extinguishment of debt

 

 

39,999

 

Other income

 

1,923

 

3,004

 

Total other income

 

46,436

 

71,107

 

Non-investment expenses:

 

 

 

 

 

Related party management compensation

 

21,201

 

20,491

 

General, administrative and directors expenses

 

8,171

 

3,350

 

Professional services

 

1,432

 

1,064

 

Total non-investment expenses

 

30,804

 

24,905

 

Income before income tax expense

 

95,084

 

129,511

 

Income tax expense

 

1,317

 

16

 

Net income

 

$

93,767

 

$

129,495

 

 

 

 

 

 

 

Net income per common share:

 

 

 

 

 

Basic

 

$

0.53

 

$

0.82

 

Diluted

 

$

0.51

 

$

0.82

 

 

 

 

 

 

 

Weighted-average number of common shares outstanding:

 

 

 

 

 

Basic

 

177,075

 

156,997

 

Diluted

 

181,292

 

156,997

 

 

See notes to condensed consolidated financial statements.

 

4



Table of Contents

 

KKR Financial Holdings LLC and Subsidiaries

Condensed Consolidated Statements of Changes in Shareholders’ Equity

(Unaudited)

(Amounts in thousands)

 

 

 

Common
Shares

 

Paid-In
Capital

 

Accumulated
Other
Comprehensive
Income

 

Accumulated
Deficit

 

Comprehensive
Income

 

Total
Shareholders’
Equity

 

Balance at January 1, 2011

 

177,849

 

$

2,756,200

 

$

133,596

 

$

(1,246,748

)

 

 

$

1,643,048

 

Net income

 

 

 

 

93,767

 

$

93,767

 

93,767

 

Net change in unrealized loss on cash flow hedges

 

 

 

8,192

 

 

8,192

 

8,192

 

Net change in unrealized gain on securities available-for-sale

 

 

 

12,904

 

 

12,904

 

12,904

 

Comprehensive income

 

 

 

 

 

$

114,863

 

 

 

Cash distributions on common shares

 

 

 

 

(26,719

)

 

 

(26,719

)

Issuance of common shares

 

171

 

1,297

 

 

 

 

 

1,297

 

Grant of restricted common shares

 

241

 

 

 

 

 

 

 

Repurchase and cancellation of common shares

 

(133

)

(1,297

)

 

 

 

 

(1,297

)

Share-based compensation expense related to restricted common shares

 

 

1,833

 

 

 

 

 

1,833

 

Balance at March 31, 2011

 

178,128

 

$

2,758,033

 

$

154,692

 

$

(1,179,700

)

 

 

$

1,733,025

 

 

See notes to condensed consolidated financial statements.

 

5



Table of Contents

 

KKR Financial Holdings LLC and Subsidiaries

Condensed Consolidated Statements of Cash Flows

(Unaudited)

(Amounts in thousands)

 

 

 

For the three months
ended March 31, 2011

 

For the three months
ended March 31, 2010

 

Cash flows from operating activities:

 

 

 

 

 

Net income

 

$

93,767

 

$

129,495

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

Net realized and unrealized (gain) loss on derivatives and foreign exchange

 

(6,067

)

1,418

 

Net gain on restructuring and extinguishment of debt

 

 

(39,999

)

Write-off of debt issuance costs

 

450

 

1,679

 

Lower of cost or estimated fair value adjustment on corporate loans held for sale

 

(1,567

)

(3,720

)

Provision for loan losses

 

11,661

 

 

Impairment on securities available-for-sale and private equity investments at cost

 

975

 

1,140

 

Share-based compensation

 

1,833

 

2,894

 

Net unrealized loss on residential mortgage-backed securities, residential mortgage loans, and residential mortgage-backed securities issued, carried at estimated fair value

 

738

 

5,145

 

Net realized and unrealized gain on sales of investments

 

(38,592

)

(32,087

)

Deferred interest expense

 

 

2,707

 

Depreciation and net amortization

 

(25,576

)

(23,623

)

Changes in assets and liabilities:

 

 

 

 

 

Interest receivable

 

2,394

 

6,718

 

Other assets

 

(2,800

)

(4,835

)

Related party payable

 

2,778

 

11,460

 

Accounts payable, accrued expenses and other liabilities

 

(47

)

509

 

Accrued interest payable

 

(6,613

)

(8,700

)

Accrued interest payable to affiliates

 

748

 

(761

)

Net cash provided by operating activities

 

34,082

 

49,440

 

Cash flows from investing activities:

 

 

 

 

 

Principal payments from corporate loans

 

551,504

 

478,748

 

Principal payments from securities available-for-sale

 

39,145

 

71,842

 

Principal payments from residential mortgage-backed securities, at estimated fair value

 

1,901

 

4,133

 

Proceeds from sale of corporate loans

 

62,750

 

275,047

 

Proceeds from sale of securities available-for-sale

 

32,992

 

131,409

 

Proceeds from sale of equity investments

 

6,020

 

76,529

 

Proceeds from securities sold, not yet purchased

 

20,401

 

 

Purchases of corporate loans

 

(763,390

)

(587,934

)

Purchases of securities available-for-sale

 

(48,729

)

(207,783

)

Cover securities sold, not yet purchased

 

(19,180

)

(78,727

)

Purchases of equity and other investments

 

(69,722

)

(7,332

)

Net proceeds, purchases, and settlements of derivatives

 

249

 

13,748

 

Net change in reverse repurchase agreements

 

 

80,250

 

Net change in restricted cash and cash equivalents

 

(19,811

)

(38,592

)

Net cash (used in) provided by investing activities

 

(205,870

)

211,338

 

Cash flows from financing activities:

 

 

 

 

 

Issuance of collateralized loan obligation secured debt

 

125,837

 

 

Retirement of collateralized loan obligation secured debt

 

(110,426

)

(102,002

)

Retirement of collateralized loan obligation junior secured notes to affiliates

 

(276

)

(51,654

)

Repayment of credit facilities

 

 

(25,000

)

Proceeds from convertible senior notes

 

 

167,325

 

Repayment of convertible senior notes

 

 

(93,922

)

Distributions on common shares

 

(26,719

)

(11,085

)

Issuance of common shares

 

1,297

 

 

Repurchase and cancellation of common shares

 

(1,297

)

 

Other capitalized costs

 

(1,125

)

(997

)

Net cash used in financing activities

 

(12,709

)

(117,335

)

Net (decrease) increase in cash and cash equivalents

 

(184,497

)

143,443

 

Cash and cash equivalents at beginning of period

 

313,829

 

97,086

 

Cash and cash equivalents at end of period

 

$

129,332

 

$

240,529

 

Supplemental cash flow information:

 

 

 

 

 

Cash paid for interest

 

$

41,879

 

$

37,387

 

Net cash paid for income taxes

 

$

31

 

$

6

 

Non-cash investing and financing activities:

 

 

 

 

 

Deconsolidation of residential mortgage loans

 

$

 

$

2,034,772

 

Deconsolidation of residential mortgage-backed securities issued

 

$

 

$

(2,034,772

)

Subordinate tranche of the residential mortgage loan securitization trusts included in residential mortgage-backed securities

 

$

 

$

74,366

 

Equity component of the convertible senior notes

 

$

 

$

9,973

 

Loans transferred from held for investment to held for sale

 

$

582,878

 

$

190,338

 

Loans transferred from held for sale to held for investment

 

$

97,857

 

$

80,008

 

 

See notes to condensed consolidated financial statements.

 

6


 


Table of Contents

 

KKR Financial Holdings LLC and Subsidiaries

 

Notes to Condensed Consolidated Financial Statements

 

Note 1. Organization

 

KKR Financial Holdings LLC together with its subsidiaries (the “Company” or “KKR Financial”) is a specialty finance company with expertise in a range of asset classes. The Company’s core business strategy is to leverage the proprietary resources of its manager with the objective of generating both current income and capital appreciation by deploying capital to its strategies, which include bank loans and high yield securities, mezzanine, special situations, natural resources, commercial real estate and private equity. The Company’s holdings across these strategies primarily consist of below investment grade syndicated corporate loans, also known as leveraged loans, high yield debt securities and private equity. The corporate loans that the Company holds are purchased via assignment or participation in the primary or secondary market. In addition to the financial instruments the Company holds across its strategies, the Company deploys capital to both working and royalty interests in oil and gas properties through its natural resources strategy.

 

The majority of the Company’s holdings consist of corporate loans and high yield debt securities held in collateralized loan obligation (“CLO”) transactions that are structured as on-balance sheet securitizations and are used as long term financing for the Company’s investments in corporate debt. The senior secured debt issued by the CLO transactions is generally owned by unaffiliated third party investors and the Company owns the majority of the mezzanine and subordinated notes in the CLO transactions. The Company executes its core business strategy through its majority-owned subsidiaries, including CLOs.

 

KKR Financial Advisors LLC (the “Manager”), a wholly-owned subsidiary of KKR Asset Management LLC, manages the Company pursuant to a management agreement (the “Management Agreement”). KKR Asset Management LLC is a wholly-owned subsidiary of Kohlberg Kravis Roberts & Co. L.P. (“KKR”).

 

Note 2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). The condensed consolidated financial statements include the accounts of the Company and entities established to complete secured financing transactions that are considered to be variable interest entities and for which the Company is the primary beneficiary.

 

These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2010. The Company’s results for any interim period are not necessarily indicative of results for a full year or any other interim period. In the opinion of management, all normal recurring adjustments have been included for a fair statement of this interim financial information.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s condensed consolidated financial statements and accompanying notes. Actual results could differ from management’s estimates.

 

Consolidation

 

Effective January 1, 2010, the Company adopted new accounting guidance which amended the accounting for the transfers of financial assets, eliminated the concept of a qualified special purpose entity and significantly changed the criteria by which an enterprise determines whether or not it must consolidate a variable interest entity (“VIE”). Under the new accounting guidance, consolidation of a VIE requires both the power to direct the activities that most significantly impact the VIE’s economic performance and the obligation to absorb losses of the VIE or the right to receive benefits of the VIE that could potentially be significant to the VIE.

 

7



Table of Contents

 

As a result of the adoption of the new accounting guidance regarding the amended consolidation model based on power and economics, the Company determined that six residential mortgage loan securitization trusts, which were previously consolidated by the Company as it was deemed to be the primary beneficiary, were required to be deconsolidated. The Company determined that it did not have the power to direct the activities that most significantly impact the economic performance of the securitization trusts or the performance of the securitization trusts’ underlying assets as the Company was never the servicer of the trusts nor did it participate in any servicing activities. Accordingly, the Company determined that it was no longer the primary beneficiary of the six securitization trusts under the new accounting guidance and deconsolidated them as of January 1, 2010. This resulted in the reduction of both assets and liabilities of approximately $2.0 billion. In addition, loan interest income, interest expense, loan servicing expense, and net unrealized and realized gain (loss) associated with the residential mortgage loan securitization trusts are no longer reported on the Company’s condensed consolidated financial statements. The deconsolidation of the six residential mortgage loan securitization trusts had no net impact on the Company’s shareholders’ equity, results of operations and cash flows. Refer to Note 6 to these condensed consolidated financial statements for the impact of the deconsolidation.

 

KKR Financial CLO 2005-1, Ltd. (“CLO 2005-1”), KKR Financial CLO 2005-2, Ltd. (“CLO 2005-2”), KKR Financial CLO 2006-1, Ltd. (“CLO 2006-1”), KKR Financial CLO 2007-1, Ltd. (“CLO 2007-1”), KKR Financial CLO 2007-A, Ltd. (“CLO 2007-A”), and KKR Financial CLO 2011-1, Ltd. (“CLO 2011-1”) are entities established to complete secured financing transactions. These entities are VIEs which the Company consolidates as the Company has determined it has the power to direct the activities that most significantly impact these entities’ economic performance and the Company has both the obligation to absorb losses of these entities and the right to receive benefits from these entities that could potentially be significant to these entities.

 

These six CLOs, through which the Company finances the majority of its corporate debt investments, include $7.2 billion par amount, or $7.1 billion estimated fair value, of corporate debt investments as of March 31, 2011. The assets in each CLO can be used only to settle the related entities’ debt which in aggregate totaled $5.6 billion of secured debt outstanding held by unaffiliated third parties and $365.8 million of junior notes outstanding held by an affiliate of the Manager. In CLO transactions, subordinated notes have the first risk of loss and conversely, the residual value upside of the transactions. As such, these CLOs are considered non-recourse leverage to the Company.

 

In addition, the Company continues to consolidate all non-VIEs in which it holds a greater than 50 percent voting interest.

 

All inter-company balances and transactions have been eliminated in consolidation.

 

Fair Value of Financial Instruments

 

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Where available, fair value is based on observable market prices or parameters or derived from such prices or parameters. Where observable prices or inputs are not available, valuation models are applied. These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the instruments or market and the instruments’ complexity for disclosure purposes. Assets and liabilities recorded at fair value in the condensed consolidated balance sheets are categorized based upon the level of judgment associated with the inputs used to measure their value. Hierarchical levels, as defined under GAAP, are directly related to the amount of subjectivity associated with the inputs to fair valuations of these assets and liabilities, and are as follows:

 

Level 1: Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.

 

The types of assets generally included in this category are equity securities listed in active markets.

 

Level 2: Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar instruments in active markets, and inputs other than quoted prices that are observable for the asset or liability.

 

The types of assets and liabilities generally included in this category are certain corporate debt securities, certain corporate loans held for sale, certain equity investments at estimated fair value, certain securities sold, not yet purchased and certain financial instruments classified as derivatives.

 

8



Table of Contents

 

Level 3: Inputs are unobservable inputs for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls has been determined based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and consideration of factors specific to the asset.

 

The types of assets and liabilities generally included in this category are certain corporate debt securities, certain corporate loans held for sale, certain equity investments, at estimated fair value, and residential mortgage backed securities (“RMBS”), at estimated fair value.

 

A significant decrease in the volume and level of activity for the asset or liability is an indication that transactions or quoted prices may not be representative of fair value because in such market conditions there may be increased instances of transactions that are not orderly. In those circumstances, further analysis of transactions or quoted prices is needed, and a significant adjustment to the transactions or quoted prices may be necessary to estimate fair value.

 

The availability of observable inputs can vary depending on the financial asset or liability and is affected by a wide variety of factors, including, for example, the type of product, whether the product is new, whether the product is traded on an active exchange or in the secondary market, and the current market condition. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety. The variability of the observable inputs affected by the factors described above may cause transfers between Levels 1, 2, and/or 3, which the Company recognizes at the end of the reporting period.

 

Many financial assets and liabilities have bid and ask prices that can be observed in the marketplace. Bid prices reflect the highest price that the Company and others are willing to pay for an asset. Ask prices represent the lowest price that the Company and others are willing to accept for an asset. For financial assets and liabilities whose inputs are based on bid-ask prices, the Company does not require that fair value always be a predetermined point in the bid-ask range. The Company’s policy is to allow for mid-market pricing and adjusting to the point within the bid-ask range that meets the Company’s best estimate of fair value.

 

Depending on the relative liquidity in the markets for certain assets, the Company may transfer assets to Level 3 if it determines that observable quoted prices, obtained directly or indirectly, are not available. The valuation techniques used for the assets and liabilities that are valued using Level 3 of the fair value hierarchy are described below.

 

Corporate Debt Securities:  Corporate debt securities are initially valued at transaction price and are subsequently valued using market data for similar instruments (e.g., recent transactions or broker quotes), comparisons to benchmark derivative indices or valuation models. Valuation models are based on discounted cash flow techniques, for which the key inputs are the amount and timing of expected future cash flows, market yields for such instruments and recovery assumptions. Inputs are determined based on relative value analyses, which incorporate similar instruments from similar issuers.

 

Equity Investments, at Estimated Fair Value:  Equity investments, at estimated fair value, are initially valued at transaction price and are subsequently valued using observable market prices, if available, or internally developed models in the absence of readily observable market prices. Valuation models are generally based on a market and income (discounted cash flow) approach, from which various internal and external factors are considered. Factors include the price at which the investment was acquired, the nature of the investment, current market conditions, recent public market and private transactions for comparable securities, and financing transactions subsequent to the acquisition of the investment. The fair value recorded for a particular investment will generally be within the range suggested by the two approaches.

 

Over-the-counter (“OTC”) Derivative Contracts:  OTC derivative contracts include forward, swap and option contracts related to interest rates, foreign currencies, credit standing of reference entities, and equity prices. The fair value of OTC derivative products can be modeled using a series of techniques, including closed-form analytic formulae, such as the Black-Scholes option-pricing model, and simulation models or a combination thereof. Many pricing models do not entail

 

9



Table of Contents

 

material subjectivity because the methodologies employed do not necessitate significant judgment, and the pricing inputs are observed from actively quoted markets, as is the case for generic interest rate swap and option contracts.

 

Residential Mortgage-Backed Securities, at Estimated Fair Value:  Residential mortgage-backed securities, residential mortgage loans, and residential mortgage-backed securities issued are initially valued at transaction price and are subsequently valued using industry recognized models (including Intex and Bloomberg) and data for similar instruments (e.g., nationally recognized pricing services or broker quotes). The most significant inputs to the valuation of these instruments are default and loss expectations and market credit spreads.

 

Cash and Cash Equivalents

 

Cash and cash equivalents include cash on hand, cash held in banks and highly liquid investments with original maturities of three months or less. Interest income earned on cash and cash equivalents is recorded in other interest income.

 

Restricted Cash and Cash Equivalents

 

Restricted cash and cash equivalents represent amounts that are held by third parties under certain of the Company’s financing and derivative transactions. Interest income earned on restricted cash and cash equivalents is recorded in other interest income.

 

On the condensed consolidated statement of cash flows, net additions or reductions to restricted cash and cash equivalents are classified as an investing activity as restricted cash and cash equivalents reflect the receipts from collections or sales of investments, as well as payments made to acquire investments held by third parties.

 

Residential Mortgage-Backed Securities

 

The Company carries its residential mortgage-backed securities at estimated fair value with unrealized gains and losses reported in income. The Company elected the fair value option for its residential mortgage investments for the purpose of enhancing the transparency of its financial condition as fair value is consistent with how the Company manages the risks of its residential mortgage investments.

 

Securities Available-for-Sale

 

The Company classifies its investments in securities as available-for-sale as the Company may sell them prior to maturity and does not hold them principally for the purpose of selling them in the near term. These investments are carried at estimated fair value, with unrealized gains and losses reported in accumulated other comprehensive income. Estimated fair values are based on quoted market prices, when available, on estimates provided by independent pricing sources or dealers who make markets in such securities, or internal valuation models when external sources of fair value are not available. Upon the sale of a security, the realized net gain or loss is computed on a weighted average cost basis. Purchases and sales of securities are recorded on the trade date.

 

The Company monitors its available-for-sale securities portfolio for impairments. A loss is recognized when it is determined that a decline in the estimated fair value of a security below its amortized cost is other-than-temporary. The Company considers many factors in determining whether the impairment of a security is deemed to be other-than-temporary, including, but not limited to, the length of time the security has had a decline in estimated fair value below its amortized cost and the severity of the decline, the amount of the unrealized loss, recent events specific to the issuer or industry, external credit ratings and recent changes in such ratings. In addition, for debt securities, the Company considers its intent to sell the debt security, the Company’s estimation of whether or not it expects to recover the debt security’s entire amortized cost if it intends to hold the debt security, and whether it is more likely than not that the Company will be required to sell the debt security before its anticipated recovery. For equity securities, the Company also considers its intent and ability to hold the equity security for a period of time sufficient for a recovery in value.

 

The amount of the loss that is recognized when it is determined that a decline in the estimated fair value of a security below its amortized cost is other-than-temporary is dependent on certain factors. If the security is an equity security or if the security is a debt security that the Company intends to sell or estimates that it is more likely than not that the Company will be required to sell before recovery of its amortized cost, then the impairment amount recognized in earnings is the entire difference between the estimated fair value of the security and its amortized cost. For debt securities that the Company does not intend to sell or estimates that it is not more likely than not to be required to sell before recovery, the impairment is

 

10



Table of Contents

 

separated into the estimated amount relating to credit loss and the estimated amount relating to all other factors. Only the estimated credit loss amount is recognized in earnings, with the remainder of the loss amount recognized in other comprehensive income (loss).

 

Unamortized premiums and unaccreted discounts on securities available-for-sale are recognized in interest income over the contractual life, adjusted for actual prepayments, of the securities using the effective interest method.

 

Securities available-for-sale acquired with deteriorated credit quality are recorded at initial cost and interest income is recognized as the difference between the Company’s estimate of all cash flows that it will receive from the loan in excess of its initial investment on a level-yield basis over the life of the loan (accretable yield) using the effective interest method.

 

Equity Investments, at Estimated Fair Value

 

The Company has elected the fair value option of accounting for certain marketable equity securities and private equity investments. The Company elects the fair value option of accounting for private equity investments received through restructuring debt transactions or issued by an entity in which the Company may have significant influence. The Company elected the fair value option for certain equity investments for the purpose of enhancing the transparency of its financial condition as fair value is consistent with how the Company manages the risks of these equity investments. Equity investments, at fair value, are managed based on overall value and potential returns. Investments carried at fair value are presented separately on the condensed consolidated balance sheets with unrealized gains and losses reported in net realized and unrealized gains and losses on investments on the condensed consolidated statements of operations.

 

Securities Sold, Not Yet Purchased

 

Securities sold, not yet purchased consist of equity and debt securities that the Company has sold short. In order to facilitate a short sale, the Company borrows the securities from another party and delivers the securities to the buyer. The Company will be required to “cover” its short sale in the future through the purchase of the security in the market at the prevailing market price and deliver it to the counterparty from which it borrowed. The Company is exposed to a loss to the extent that the security price increases during the time from when the Company borrowed the security to when the Company purchases it in the market to cover the short sale.

 

Corporate Loans

 

Corporate loans are generally held for investment and the Company initially records loans at their purchase prices. The Company subsequently accounts for loans based on their outstanding principal plus or minus unaccreted purchase discounts and unamortized purchase premiums. Corporate loans that the Company transfers to held for sale are transferred at the lower of cost or estimated fair value.

 

Interest income on loans includes interest at stated coupon rates adjusted for accretion of purchase discounts and the amortization of purchase premiums. Unamortized premiums and unaccreted discounts are recognized in interest income over the contractual life, adjusted for actual prepayments, of the loans using the effective interest method.

 

A loan is typically placed on non-accrual status at such time as: (i) management believes that scheduled debt service payments may not be paid when contractually due; (ii) the loan becomes 90 days delinquent; (iii) management determines the borrower is incapable of, or has ceased efforts toward, curing the cause of the impairment; or (iv) the net realizable value of the underlying collateral securing the loan decreases below the Company’s carrying value of such loan. As such, loans placed on non-accrual status may or may not be contractually past due at the time of such determination. While on non-accrual status, previously recognized accrued interest is reversed if it is determined that such amounts are not collectible and interest income is recognized using the cost-recovery method, cash-basis method or some combination of the two methods. A loan is placed back on accrual status when the ultimate collectability of the principal and interest is not in doubt.

 

The Company may modify corporate loans in transactions where the borrower is experiencing financial difficulty and a concession is granted to the borrower as part of the modification. These concessions may include a reduction in interest rate, payment extensions, forgiveness of principal, an exchange of assets or a combination thereof. Such modifications typically qualify as troubled debt restructurings.

 

In addition, the Company may also modify corporate loans which usually involve changes in existing interest rates combined with changes of existing maturities to prevailing market rates/maturities for similar instruments at the time of

 

11



Table of Contents

 

modification. Such modifications typically do not meet the definition of a troubled debt restructuring since the respective borrowers are neither experiencing financial difficulty nor are seeking a concession as part of the modification.

 

The corporate loans the Company invests in are generally deemed in default upon the non-payment of a single interest payment or as a result of the violation of a covenant in the respective loan agreement. The Company charges-off a portion or all of its amortized cost basis in a corporate loan when it determines that it is uncollectible due to either: i) the estimation based on a recovery value analysis of a defaulted loan that less than the amortized cost amount will be recovered through the agreed upon restructuring of the loan or as a result of a bankruptcy process of the issuer of the loan; or ii) the determination by the Company to transfer a loan to held for sale with the loan having an estimated market value below the amortized cost basis of the loan.

 

Loans acquired with deteriorated credit quality are recorded at initial cost and interest income is recognized as the difference between the Company’s estimate of all cash flows that it will receive from the loan in excess of its initial investment on a level-yield basis over the life of the loan (accretable yield) using the effective interest method.

 

Corporate Loans Held for Sale

 

From time to time the Company makes the determination to transfer certain of its corporate loans from held for investment to held for sale. The decision to transfer a loan to held for sale is generally as a result of the Company determining that the respective loan’s credit quality in relation to the loan’s expected risk-adjusted return no longer meets the Company’s investment objective and/or the Company deciding to reduce or eliminate its exposure to a particular loan for risk management purposes. Corporate loans held for sale are stated at lower of cost or estimated fair value and are assessed on an individual basis. Corporate loans that the Company transfers to held for investment are transferred at the lower of cost or estimated fair value.

 

Interest income on corporate loans classified as held for sale is recognized through accrual of the stated coupon rate for the loans, unless the loans are placed on non-accrual status, at which point previously recognized accrued interest is reversed if it is determined that such amounts are not collectible and interest income is recognized using either the cost-recovery method or on a cash-basis.

 

Allowance for Loan Losses

 

The Company’s corporate loan portfolio is comprised of a single portfolio segment which includes one class of financing receivables, that is, high yield loans that are purchased via assignment or participation in either the primary or secondary market and are held primarily for investment. High yield loans are generally characterized as having below investment grade ratings or being unrated and generally consist of leveraged loans.

 

The Company’s allowance for loan losses represents its estimate of probable credit losses inherent in its corporate loan portfolio held for investment as of the balance sheet date. Estimating the Company’s allowance for loan losses involves a high degree of management judgment and is based upon a comprehensive review of the Company’s loan portfolio that is performed on a quarterly basis. The Company’s allowance for loan losses consists of two components, an allocated component and an unallocated component. The allocated component of the allowance for loan losses pertains to specific loans that the Company has determined are impaired. The Company determines a loan is impaired when management estimates that it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the loan agreement. On a quarterly basis the Company performs a comprehensive review of its entire loan portfolio and identifies certain loans that it has determined are impaired. Once a loan is identified as being impaired, the Company places the loan on non-accrual status, unless the loan is already on non-accrual status, and records a reserve that reflects management’s best estimate of the loss that the Company expects to recognize from the loan. The expected loss is estimated as being the difference between the Company’s current cost basis of the loan, including accrued interest receivable, and the loan’s estimated fair value.

 

The unallocated component of the Company’s allowance for loan losses represents its estimate of probable losses inherent in the loan portfolio as of the balance sheet date where the specific loan that the loan loss relates to is indeterminable. The Company estimates the unallocated component of the allowance for loan losses through a comprehensive review of its loan portfolio and identifies certain loans that demonstrate possible indicators of impairment, including internally assigned credit quality indicators. This assessment excludes all loans that are determined to be impaired and as a result, an allocated reserve has been recorded as described in the preceding paragraph. Such indicators include, but are not limited to, the current and/or forecasted financial performance and liquidity profile of the issuer, specific industry or

 

12



Table of Contents

 

economic conditions that may impact the issuer, and the observable trading price of the loan if available. All loans are first categorized based on their assigned risk grade and further stratified based on the seniority of the loan in the issuer’s capital structure. The seniority classifications assigned to loans are senior secured, second lien and subordinate. Senior secured consists of loans that are the most senior debt in an issuer’s capital structure and therefore have a lower estimated loss severity than other debt that is subordinate to the senior secured loan. Senior secured loans often have a first lien on some or all of the issuer’s assets. Second lien consists of loans that are secured by a second lien interest on some or all of the issuer’s assets; however, the loan is subordinate to the first lien debt in the issuer’s capital structure. Subordinate consists of loans that are generally unsecured and subordinate to other debt in the issuer’s capital structure.

 

There are three internally assigned risk grades that are applied to loans that have not been identified as being impaired: high, moderate and low. High risk means that there is evidence of probable loss due to the financial or operating performance and liquidity of the issuer, industry or economic concerns specific to the issuer, or other factors that indicate that the breach of a covenant contained in the related loan agreement is possible. Moderate risk means that while there is not observable evidence of loss, there are issuer and/or industry specific trends that indicate a loss may have occurred. Low risk means that while there is no identified evidence of loss, there is the risk of loss inherent in the loan that has not been identified. All loans held for investment, with the exception of loans that have been identified as impaired, are assigned a risk grade of high, moderate or low.

 

The Company applies a range of default and loss severity estimates in order to estimate a range of loss outcomes upon which to base its estimate of probable losses that results in the determination of the unallocated component of the Company’s allowance for loan losses.

 

Borrowings

 

The Company finances the majority of its investments through the use of secured borrowings in the form of securitization transactions structured as secured financings and other secured and unsecured borrowings. In addition the Company finances certain of its oil and gas asset acquisitions through borrowings. The Company recognizes interest expense on all borrowings on an accrual basis.

 

Trust Preferred Securities

 

Trusts formed by the Company for the sole purpose of issuing trust preferred securities are not consolidated by the Company as the Company has determined that it is not the primary beneficiary of such trusts. The Company’s investment in the common securities of such trusts is included in other assets on the Company’s condensed consolidated financial statements.

 

Derivative Financial Instruments

 

The Company recognizes all derivatives on the condensed consolidated balance sheet at estimated fair value. On the date the Company enters into a derivative contract, the Company designates and documents each derivative contract as one of the following at the time the contract is executed: (i) a hedge of a recognized asset or liability (“fair value” hedge); (ii) a hedge of a forecasted transaction or of the variability of cash flows to be received or paid related to a recognized asset or liability (“cash flow” hedge); (iii) a hedge of a net investment in a foreign operation; or (iv) a derivative instrument not designated as a hedging instrument (“free-standing derivative”). For a fair value hedge, the Company records changes in the estimated fair value of the derivative instrument and, to the extent that it is effective, changes in the fair value of the hedged asset or liability in the current period earnings in the same financial statement category as the hedged item. For a cash flow hedge, the Company records changes in the estimated fair value of the derivative to the extent that it is effective in other comprehensive (loss) income and subsequently reclassifies these changes in estimated fair value to net income in the same period(s) that the hedged transaction affects earnings. The effective portion of the cash flow hedges is recorded in the same financial statement category as the hedged item. For free-standing derivatives, the Company reports changes in the fair values in other (loss) income.

 

The Company formally documents at inception its hedge relationships, including identification of the hedging instruments and the hedged items, its risk management objectives, strategy for undertaking the hedge transaction and the Company’s evaluation of effectiveness of its hedged transactions. Periodically, the Company also formally assesses whether the derivative it designated in each hedging relationship is expected to be and has been highly effective in offsetting changes in estimated fair values or cash flows of the hedged item using either the dollar offset or the regression analysis method. If the Company determines that a derivative is not highly effective as a hedge, it discontinues hedge accounting.

 

13



Table of Contents

 

Foreign Currency

 

The Company makes investments in non-United States dollar denominated securities and loans. As a result, the Company is subject to the risk of fluctuation in the exchange rate between the United States dollar and the foreign currency in which it makes an investment. In order to reduce the currency risk, the Company may hedge the applicable foreign currency. All investments denominated in a foreign currency are converted to the United States dollar using prevailing exchange rates on the balance sheet date. Income, expenses, gains and losses on investments denominated in a foreign currency are converted to the United States dollar using the prevailing exchange rates on the dates when they are recorded. Foreign exchange gains and losses are recorded in the condensed consolidated statements of operations.

 

Manager Compensation

 

The Management Agreement provides for the payment of a base management fee to the Manager, as well as an incentive fee if the Company’s financial performance exceeds certain benchmarks. Additionally, the Management Agreement provides for the Manager to be reimbursed for certain expenses incurred on the Company’s behalf. See Note 12 to these condensed consolidated financial statements for additional discussion on the payment of the base management fee and incentive fee. The base management fee and the incentive fee are accrued and expensed during the period for which they are earned by the Manager.

 

Share-Based Compensation

 

The Company accounts for share-based compensation issued to its directors and to its Manager using the fair value based methodology in accordance with relevant accounting guidance. Compensation cost related to restricted common shares issued to the Company’s directors is measured at its estimated fair value at the grant date, and is amortized and expensed over the vesting period on a straight-line basis. Compensation cost related to restricted common shares and common share options issued to the Manager is initially measured at estimated fair value at the grant date, and is remeasured on subsequent dates to the extent the awards are unvested. The Company has elected to use the graded vesting attribution method to amortize compensation expense for the restricted common shares and common share options granted to the Manager.

 

Income Taxes

 

The Company intends to continue to operate so as to qualify, for United States federal income tax purposes, as a partnership and not as an association or publicly traded partnership taxable as a corporation. Therefore, the Company generally is not subject to United States federal income tax at the entity level, but is subject to limited state and foreign taxes. Holders of the Company’s shares will be required to take into account their allocable share of each item of the Company’s income, gain, loss, deduction, and credit for the taxable year of the Company ending within or with their taxable year.

 

During 2011, the Company owned an equity interest in KKR Financial Holdings II, LLC (“KFH II”), which elected to be taxed as a real estate investment trust (a “REIT”) under the Internal Revenue Code of 1986, as amended (the “Code”). KFH II holds certain real estate mortgage-backed securities. A REIT generally is not subject to United States federal income tax to the extent that it currently distributes its income and satisfies certain asset, income and ownership tests, and recordkeeping requirements, but it may be subject to some amount of federal, state, local and foreign taxes based on its taxable income.

 

The Company has wholly-owned domestic and foreign subsidiaries that are taxable as corporations for United States federal income tax purposes and thus are not consolidated with the Company for United States federal income tax purposes. For financial reporting purposes, current and deferred taxes are provided for on the portion of earnings recognized by the Company with respect to its interest in the domestic taxable corporate subsidiaries, because each is taxed as a regular corporation under the Code. Deferred income tax assets and liabilities are computed based on temporary differences between the GAAP condensed consolidated financial statements and the United States federal income tax basis of assets and liabilities as of each condensed consolidated balance sheet date. The foreign corporate subsidiaries were formed to make certain foreign and domestic investments from time to time. The foreign corporate subsidiaries are organized as exempted companies incorporated with limited liability under the laws of the Cayman Islands, and are anticipated to be exempt from United States federal and state income tax at the corporate entity level because they restrict their activities in the United States to trading in stock and securities for their own account. However, the Company will be required to include their current taxable income in the Company’s calculation of its taxable income allocable to shareholders. CLO 2005-1, CLO 2005-2, CLO 2006-1, CLO 2007-1, CLO 2007-A, KKR Financial CLO 2009-1, Ltd. (“CLO 2009-1”) and CLO 2011-1 are foreign subsidiaries of the Company that elected to be treated as disregarded entities or partnerships for United States federal income tax purposes. These subsidiaries were established to facilitate securitization transactions, structured as secured financing transactions.

 

14



Table of Contents

 

Earnings Per Share

 

The Company calculates earnings per share (“EPS”) using the two-class method which is an earnings allocation formula that determines EPS for common shares and participating securities. Unvested share-based payment awards that contain non-forfeitable rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and shall be included in the computation of EPS using the two-class method. Accordingly, all earnings (distributed and undistributed) are allocated to common shares and participating securities based on their respective rights to receive dividends.

 

The Company presents both basic and diluted earnings per common share in its condensed consolidated financial statements and footnotes thereto. Basic earnings per common share (“Basic EPS”) excludes dilution and is computed by dividing net income or loss by the weighted average number of common shares, including vested restricted common shares, outstanding for the period. Diluted earnings per share (“Diluted EPS”) reflects the potential dilution of common share options and unvested restricted common shares using the treasury method, as well as the potential dilution of convertible senior notes using the number of shares it would take to satisfy the excess conversion obligation (average Company share price for the period in excess of the conversion price related to the Company’s convertible senior notes), if they are not anti-dilutive. See Note 3 to these condensed consolidated financial statements for earnings per common share computations.

 

Recent Accounting Pronouncements

 

Receivables — Troubled Debt Restructurings

 

In April 2011, the Financial Accounting Standards Board (“FASB”) amended existing standards to provide additional guidance in evaluating whether a restructuring constitutes a troubled debt restructuring, including whether a creditor has granted a concession and whether a debtor is experiencing financial difficulties. The guidance is effective for the first interim or annual reporting period beginning on or after June 15, 2011 and should be applied retrospectively to the beginning of the annual period of adoption; early adoption is permitted. As a result of applying these amendments, an entity may identify receivables that are newly considered impaired. For purposes of measuring impairment of those receivables, an entity should apply the amendments prospectively for the first interim or annual period beginning on or after June 15, 2011. An entity shall disclose the total amount of receivables and the allowance for credit losses as of the end of the period of adoption related to those receivables that are newly considered impaired. The Company does not believe the adoption of this new guidance will have a material impact on its condensed consolidated financial statements.

 

Note 3. Earnings per Share

 

The following table presents a reconciliation of basic and diluted net income per common share for the three months ended March 31, 2011 and 2010 (amounts in thousands, except per share information), as well as the distributions declared per common share during the quarters ended March 31, 2011 and March 31, 2010:

 

 

 

Three months ended
March 31, 2011

 

Three months ended
March 31, 2010

 

Income from continuing operations

 

$

93,767

 

$

129,495

 

Less: Dividends and undistributed earnings allocated to participating securities

 

612

 

1,106

 

Net income applicable to common shareholders

 

$

93,155

 

$

128,389

 

 

 

 

 

 

 

Basic:

 

 

 

 

 

Basic weighted average shares outstanding

 

177,075

 

156,997

 

Net income per share

 

$

0.53

 

$

0.82

 

 

 

 

 

 

 

Diluted:

 

 

 

 

 

Basic weighted average shares outstanding

 

177,075

 

156,997

 

Dilutive effect of restricted common shares and convertible senior notes

 

4,217

 

 

Diluted weighted average shares outstanding(1)

 

181,292

 

156,997

 

Net income per share

 

$

0.51

 

$

0.82

 

 

 

 

 

 

 

Distributions declared per common share

 

$

0.15

 

$

0.07

 

 


(1)                                  An immaterial conversion premium related to the convertible senior notes was included in the diluted earnings per share for the three months ended March 31, 2010. Potential anti-dilutive common shares excluded from diluted earnings per share related to common share options were 1,932,279 for the three months ended March 31, 2011 and 2010.

 

15



Table of Contents

 

Note 4. Securities Available-for-Sale

 

The following table summarizes the Company’s securities classified as available-for-sale as of March 31, 2011 and December 31, 2010, which are carried at estimated fair value (amounts in thousands):

 

 

 

March 31, 2011

 

December 31, 2010

 

 

 

Amortized
Cost

 

Gross
Unrealized
Gains

 

Gross
Unrealized
Losses

 

Estimated
Fair Value

 

Amortized
Cost

 

Gross
Unrealized
Gains

 

Gross
Unrealized
Losses

 

Estimated
Fair Value

 

Corporate debt securities

 

$

638,032

 

$

204,305

 

$

(2,058

)

$

840,279

 

$

646,638

 

$

192,496

 

$

(3,614

)

$

835,520

 

Common and preferred stock

 

6,601

 

 

(204

)

6,397

 

3,117

 

257

 

 

3,374

 

Total

 

$

644,633

 

$

204,305

 

$

(2,262

)

$

846,676

 

$

649,755

 

$

192,753

 

$

(3,614

)

$

838,894

 

 

The following table shows the gross unrealized losses and fair value of the Company’s available-for-sale securities, aggregated by length of time that the individual securities have been in a continuous unrealized loss position as of March 31, 2011 and December 31, 2010 (amounts in thousands):

 

 

 

Less Than 12 months

 

12 Months or More

 

Total

 

 

 

Estimated
Fair Value

 

Unrealized
Losses

 

Estimated
Fair Value

 

Unrealized
Losses

 

Estimated
Fair Value

 

Unrealized
Losses

 

March 31, 2011

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

$

56,893

 

$

(1,731

)

$

22,023

 

$

(327

)

$

78,916

 

$

(2,058

)

Common and preferred stock

 

6,397

 

(204

)

 

 

6,397

 

(204

)

Total

 

$

63,290

 

$

(1,935

)

$

22,023

 

$

(327

)

$

85,313

 

$

(2,262

)

December 31, 2010

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate debt securities

 

$

41,656

 

$

(1,331

)

$

36,631

 

$

(2,283

)

$

78,287

 

$

(3,614

)

 

The unrealized losses in the table above are considered to be temporary impairments due to market factors and are not reflective of credit deterioration. The Company considers many factors when evaluating whether an impairment is other-than-temporary. For corporate debt securities included in the table above, the Company does not intend to sell them and does not believe that it is more likely than not that the Company will be required to sell any of its corporate debt securities prior to recovery. In addition, based on the analyses performed by the Company on each of its corporate debt securities, the Company believes that it is able to recover the entire amortized cost amount of the corporate debt securities included in the table above.

 

During the three months ended March 31, 2011 and 2010, the Company recognized losses totaling nil and $1.1 million, respectively, for corporate debt securities that it determined to be other-than-temporarily impaired. The Company intends to sell these securities and as a result, the entire amount is recorded through earnings in net realized and unrealized gain on investments in the condensed consolidated statements of operations.

 

As of March 31, 2011, the Company had corporate debt securities in default with an estimated fair value of $1.2 million from one issuer. As of December 31, 2010, the Company had corporate debt securities in default with an estimated fair value of $1.1 million from one issuer.

 

Corporate debt securities sold at a loss typically include those that the Company determined to be other-than-temporarily impaired or had a deteriorated credit quality. The following table shows the net realized gains on the sales of securities (amounts in thousands):

 

 

 

For the three
months ended
March 31, 2011

 

For the three
months ended
March 31, 2010

 

Gross realized gains

 

$

7,408

 

$

7,530

 

Gross realized losses

 

(72

)

 

Net realized gains

 

$

7,336

 

$

7,530

 

 

16


 


Table of Contents

 

The Company’s securities available-for-sale portfolio has certain credit risk concentrated in a limited number of issuers. As of March 31, 2011, approximately 57% of the estimated fair value of the Company’s securities available-for-sale portfolio was concentrated in ten issuers, with the two largest concentrations of securities available-for-sale in securities issued by NXP BV and First Data Corporation, which combined represented $203.8 million, or approximately 24% of the estimated fair value of the Company’s securities available-for-sale. As of December 31, 2010, approximately 60% of the estimated fair value of our securities available-for-sale portfolio was concentrated in ten issuers, with the two largest concentrations of securities available-for-sale in securities issued by NXP BV and First Data Corporation, which combined represented $208.6 million, or approximately 25% of the estimated fair of value of the Company's securities available-for-sale.

 

Note 7 to these condensed consolidated financial statements describes the Company’s borrowings under which the Company has pledged securities available-for-sale for borrowings. The following table summarizes the estimated fair value of securities available-for-sale pledged as collateral as of March 31, 2011 and December 31, 2010 (amounts in thousands):

 

 

 

As of
March 31, 2011

 

As of
December 31, 2010

 

Pledged as collateral for collateralized loan obligation secured debt and junior secured notes to affiliates

 

$

745,232

 

$

728,558

 

Total

 

$

745,232

 

$

728,558

 

 

Note 5. Corporate Loans and Allowance for Loan Losses

 

The following table summarizes the Company’s corporate loans as of March 31, 2011 and December 31, 2010 (amounts in thousands):

 

 

 

March 31, 2011

 

December 31, 2010

 

 

 

Corporate
Loans

 

Corporate Loans
Held for Sale

 

Total Corporate
Loans

 

Corporate
Loans

 

Corporate Loans
Held for Sale

 

Total Corporate
Loans

 

Principal(1)

 

$

6,023,125

 

$

1,019,215

 

$

7,042,340

 

$

6,398,997

 

$

481,152

 

$

6,880,149

 

Unamortized discount

 

(192,486

)

(147,708

)

(340,194

)

(332,151

)

(12,776

)

(344,927

)

Total amortized cost

 

5,830,639

 

871,507

 

6,702,146

 

6,066,846

 

468,376

 

6,535,222

 

Lower of cost or fair value adjustment

 

 

(1,699

)

(1,699

)

 

(4,748

)

(4,748

)

Allowance for loan losses

 

(198,582

)

 

(198,582

)

(209,030

)

 

(209,030

)

Net carrying value

 

$

5,632,057

 

$

869,808

 

$

6,501,865

 

$

5,857,816

 

$

463,628

 

$

6,321,444

 

 


(1)                                  Principal amount is net of charge-offs and other adjustments totaling $72.5 million and $58.2 million as of March 31, 2011 and December 31, 2010, respectively.

 

As of March 31, 2011 and December 31, 2010, the Company had an allowance for loan losses of $198.6 million and $209.0 million, respectively. As described in Note 2 to these condensed consolidated financial statements, the allowance for loan losses represents the Company’s estimate of probable credit losses inherent in its loan portfolio as of the balance sheet date. The Company’s allowance for loan losses consists of two components, an allocated component and an unallocated component. The allocated component of the allowance for loan losses consists of individual loans that are impaired. The unallocated component of the allowance for loan losses represents the Company’s estimate of losses inherent, but not identified, in its portfolio as of the balance sheet date.

 

The following table summarizes the changes in the allowance for loan losses for the Company’s corporate loan portfolio during the three months ended March 31, 2011 and 2010 (amounts in thousands):

 

 

 

For the three
months ended
March 31, 2011

 

For the three
months ended
March 31, 2010

 

Allowance for loan losses:

 

 

 

 

 

Beginning balance

 

$

209,030

 

$

237,308

 

Provision for loan losses

 

11,661

 

 

Charge-offs

 

(22,109

)

(21,228

)

Ending balance

 

$

198,582

 

$

216,080

 

 

17



Table of Contents

 

The following table summarizes the ending balances of the allowance and corporate loans portfolio by basis of impairment method as of March 31, 2011 and December 31, 2010 (amounts in thousands):

 

 

 

March 31, 2011

 

December 31, 2010

 

Allowance for loan losses:

 

 

 

 

 

Ending balance: individually evaluated for impairment

 

$

198,582

 

$

207,633

 

Ending balance: collectively evaluated for impairment

 

 

 

Ending balance: loans acquired with deteriorated credit quality

 

 

1,397

 

 

 

$

198,582

 

$

209,030

 

Corporate loans (recorded investment)(1):

 

 

 

 

 

Ending balance: individually evaluated for impairment

 

$

5,849,948

 

$

6,065,596

 

Ending balance: collectively evaluated for impairment

 

 

 

Ending balance: loans acquired with deteriorated credit quality

 

 

25,007

 

 

 

$

5,849,948

 

$

6,090,603

 

 


(1)                                  Recorded investment is defined as amortized cost plus accrued interest.

 

As of March 31, 2011, the allocated component of the allowance for loan losses totaled $20.7 million and relates to investments in certain loans issued by four issuers with an aggregate par amount of $67.0 million and an aggregate recorded investment of $56.4 million. As of December 31, 2010, the allocated component of the allowance for loan losses totaled $50.1 million and relates to investments in certain loans issued by five issuers with an aggregate par amount of $225.6 million and an aggregate recorded investment of $149.8 million.

 

The following table summarizes the Company’s recorded investment in impaired loans and the related allowance for credit losses for the three months ended March 31, 2011 and year ended December 31, 2010 (amounts in thousands):

 

 

 

Recorded
Investment

 

Unpaid
Principal
Balance

 

Related
Allowance

 

Average
Recorded
Investment

 

Interest Income
Recognized

 

March 31, 2011

 

 

 

 

 

 

 

 

 

 

 

With no related allowance recorded

 

$

 

$

 

$

 

$

8,110

 

$

 

With an allowance recorded

 

56,443

 

66,974

 

20,680

 

95,004

 

363

 

Total

 

$

56,443

 

$

66,974

 

$

20,680

 

$

103,114

 

$

363

 

 

 

 

Recorded
Investment

 

Unpaid
Principal
Balance

 

Related
Allowance

 

Average
Recorded
Investment

 

Interest Income
Recognized

 

December 31, 2010

 

 

 

 

 

 

 

 

 

 

 

With no related allowance recorded

 

$

16,219

 

$

83,215

 

$

 

$

12,873

 

$

2,853

 

With an allowance recorded

 

133,566

 

142,377

 

50,112

 

133,014

 

8,256

 

Total

 

$

149,785

 

$

225,592

 

$

50,112

 

$

145,887

 

$

11,109

 

 

As of March 31, 2011 and December 31, 2010, the allocated component of the allowance for loan losses included all impaired loans. While all of the Company’s impaired loans are on non-accrual status, the Company’s non-accrual loans also include those held for sale that are measured at the lower of cost or fair value and are not reflected in the table above.

 

As of March 31, 2011, the Company had loans on non-accrual status with total recorded investment of $148.3 million, which included $56.4 million of impaired loans that were held for investment and $91.9 million of non-accrual loans held for sale. The amount of interest income recognized using the cash-basis method during the time within the period that the loans were non-accrual was $4.0 million, which included $0.4 million for impaired loans that were held for investment and $3.6 million for non-accrual loans held for sale. As of December 31, 2010, the Company had loans on non-accrual status with total recorded investment of $165.1 million, which included $149.8 million of impaired loans that were held for investment and $15.3 million of non-accrual loans held for sale. The amount of interest income recognized using the cash-basis method during the time within the period that the loans were impaired was $5.6 million for the three months ended March 31, 2010.

 

18



Table of Contents

 

The Company did not have any corporate loans past due at March 31, 2011 and 2010.

 

The unallocated component of the allowance for loan losses totaled $177.9 million and $158.9 million as of March 31, 2011 and December 31, 2010, respectively. As described in Note 2 to these condensed consolidated financial statements, the Company estimates the unallocated components of the allowance for loan losses through a comprehensive review of its loan portfolio and identifies certain loans that demonstrate possible indicators of impairments, including credit quality indicators. The following table summarizes how the Company determines internally assigned grades related to credit quality based on a combination of concern as to probability of default and the seniority of the loan in the issuer’s capital structure as of March 31, 2011 and December 31, 2010 (amounts in thousands):

 

Internally Assigned Grade

 

Capital Hierarchy

 

Recorded Investment
March 31, 2011

 

Recorded Investment
December 31, 2010

 

High

 

Senior Secured Loan

 

$

891,284

 

$

945,435

 

 

 

Second Lien Loan

 

334,666

 

389,981

 

 

 

 

 

$

1,225,950

 

$

1,335,416

 

Moderate

 

Senior Secured Loan

 

$

482,564

 

$

494,433

 

 

 

Second Lien Loan

 

20,025

 

38,448

 

 

 

Subordinated

 

6,613

 

4,431

 

 

 

 

 

$

509,202

 

$

537,312

 

Low

 

Senior Secured Loan

 

$

3,869,006

 

$

3,829,458

 

 

 

Second Lien Loan

 

85,805

 

137,182

 

 

 

Subordinated

 

103,542

 

101,450

 

 

 

 

 

$

4,058,353

 

$

4,068,090

 

 

 

Total Unallocated

 

$

5,793,505

 

$

5,940,818

 

 

 

Total Allocated

 

56,443

 

149,785

 

 

 

Total Loans Held for Investment

 

$

5,849,948

 

$

6,090,603

 

 

During the three months ended March 31, 2011 and 2010, the Company transferred $582.8 million and $190.3 million amortized cost amount, respectively, of loans from held for investment to held for sale. The transfers of certain loans to held for sale were due to the Company’s determination that credit quality of a loan in relation to its expected risk-adjusted return no longer met the Company’s investment objective and the determination by the Company to reduce or eliminate the exposure for certain loans as part of its portfolio risk management practices. Also, during the three months ended March 31, 2011 and 2010, the Company transferred $97.9 million and $80.0 million amortized cost amount, respectively, from loans held for sale back to loans held for investment as the circumstances that led to the initial transfer to held for sale were no longer present.

 

During the three months ended March 31, 2011 and 2010, the Company recorded charge-offs totaling $22.1 million, and $21.2 million, respectively, comprised primarily of loans transferred to loans held for sale. As of March 31, 2011, the Company had $869.8 million of loans held for sale, an increase of $406.2 million from December 31, 2010 due to additional loans the Company determined it had the intention of selling.

 

As of March 31, 2011, the Company had no corporate loans in default. As of December 31, 2010, the Company held corporate loans that were in default with a total amortized cost of $18.6 million from one issuer. The majority of corporate loans in default during 2010 were included in the loans for which the allocated component of the Company’s allowance for losses was related to, or for which the Company determined were loans held for sale as of December 31, 2010.

 

The Company did not modify any loans that qualified as troubled debt restructurings during the three months ended March 31, 2011 and 2010.

 

The Company did modify $540.4 million and $68.0 million amortized cost of corporate loans during the three months ended March 31, 2011 and 2010, respectively. These modifications involved changes in existing rates and maturities to prevailing market rates/maturities for similar instruments and did not qualify as troubled debt restructurings as the respective borrowers were neither experiencing financial difficulty nor were seeking (nor granted) a concession as part of the modification. In addition, these modifications of non-troubled debt holdings were accomplished with modified loans that were not substantially different from the loans prior to modification.

 

19



Table of Contents

 

The Company’s corporate loan portfolio has certain credit risk concentrated in a limited number of issuers. As of March 31, 2011, approximately 50% of the total amortized cost basis of the Company’s corporate loan portfolio was concentrated in twenty issuers, with the three largest concentrations of corporate loans in loans issued by Texas Competitive Electric Holdings Company LLC, Modular Space Corporation, and U.S. Foodservice, which combined represented $1.1 billion, or approximately 16% of the aggregated amortized cost basis of the Company’s corporate loans. As of December 31, 2010, approximately 51% of the total amortized cost basis of the Company’s corporate loan portfolio was concentrated in twenty issuers, with the three largest concentrations of corporate loans in loans issued by Texas Competitive Electric Holdings Company LLC, Modular Space Corporation, and U.S. Foodservice, which combined represented $1.1 billion, or approximately 16% of the aggregated amortized cost basis of the Company’s corporate loans.

 

Note 7 to these condensed consolidated financial statements describes the Company’s borrowings under which the Company has pledged loans for borrowings. The following table summarizes the amortized cost of corporate loans held for sale and corporate loans pledged as collateral as of March 31, 2011 and December 31, 2010 (amounts in thousands):

 

 

 

As of
March 31, 2011

 

As of
December 31, 2010

 

Pledged as collateral for collateralized loan obligation secured debt and junior secured notes to affiliates

 

$

6,266,116

 

$

6,152,924

 

Total

 

$

6,266,116

 

$

6,152,924

 

 

Note 6. Deconsolidation of Residential Mortgage Loans Securitization Trusts

 

On January 1, 2010, the Company deconsolidated six residential mortgage securitization trusts as a result of the Company’s adoption of new accounting guidance regarding the consolidation model for variable interest entities. The Company has no exposure to loss in excess of the estimated fair value of the $74.4 million RMBS which were issued by these six residential mortgage securitization trusts.

 

The following information represents the assets and liabilities removed from the Company’s consolidated balance sheet as of January 1, 2010 as a result of the deconsolidation of the six residential mortgage loan securitization trusts (amounts in thousands):

 

 

 

As of
January 1, 2010

 

Assets

 

 

 

Residential mortgage loans, at estimated fair value(1)

 

$

2,023,333

 

Real estate owned (recorded within other assets on the consolidated balance sheets)

 

11,439

 

Interest receivable

 

4,529

 

 

 

$

2,039,301

 

Liabilities

 

 

 

Residential mortgage-backed securities issued, at estimated fair value

 

$

2,034,772

 

Accrued interest payable

 

4,529

 

 

 

$

2,039,301

 

 


(1)                                  Excludes $74.4 million which represents the estimated fair value of the Company’s RMBS which were issued by the six residential mortgage loan securitization trusts that were deconsolidated under GAAP as of January 1, 2010.

 

As a result of the deconsolidation of the six residential mortgage loan securitization trusts, all references to residential mortgage loans interest income, RMBS Issued interest expense, net realized and unrealized gain (loss) on residential mortgage loans and RMBS Issued, and loan servicing expense relate to prior period balances and activities.

 

Residential mortgage loans

 

The Company carried its residential mortgage loans at estimated fair value with unrealized gains and losses reported in income. The Company had elected the fair value option for its residential mortgage loans for the purpose of enhancing the transparency of its financial condition as fair value was consistent with how the Company managed the risks of its residential mortgage investments.

 

20



Table of Contents

 

Residential mortgage-backed securities issued

 

RMBS Issued consisted of the senior tranches of six residential mortgage loan securitization trusts that the Company previously consolidated under GAAP and for which the Company reported the debt issued by these trusts that it did not hold on its consolidated balance sheets. The Company carried RMBS Issued at estimated fair value with unrealized gains and losses reported in income. The Company elected the fair value option for its RMBS Issued for the purpose of enhancing the transparency of its financial condition as fair value was consistent with how the Company managed the risks of its residential mortgage portfolio.

 

Note 7. Borrowings

 

Certain information with respect to the Company’s borrowings as of March 31, 2011 is summarized in the following table (dollar amounts in thousands):

 

 

 

Outstanding
Borrowings

 

Weighted
Average
Borrowing
Rate

 

Weighted
Average
Remaining
Maturity
(in days)

 

Fair Value of
Collateral(1)

 

CLO 2005-1 senior secured notes

 

$

833,369

 

0.63

%

2,218

 

$

944,371

 

CLO 2005-2 senior secured notes

 

801,528

 

0.63

 

2,432

 

943,057

 

CLO 2006-1 senior secured notes

 

683,265

 

0.68

 

2,704

 

930,115

 

CLO 2007-1 senior secured notes

 

2,075,040

 

0.86

 

3,698

 

2,599,071

 

CLO 2007-1 junior secured notes(2)

 

61,491

 

 

3,698

 

77,020

 

CLO 2007-A senior secured notes

 

1,054,686

 

1.21

 

2,390

 

1,130,646

 

CLO 2007-A junior secured notes(3)

 

10,821

 

 

2,390

 

11,600

 

CLO 2011-1 senior debt(4)

 

125,837

 

1.69

 

2,559

 

 

Total collateralized loan obligation secured debt

 

5,646,037

 

 

 

 

 

6,635,880

 

CLO 2007-1 junior secured notes to affiliates(5)

 

300,396

 

 

3,698

 

374,216

 

CLO 2007-A junior secured notes to affiliates(6)

 

65,452

 

 

2,390

 

70,166

 

Total collateralized loan obligation junior secured notes to affiliates

 

365,848

 

 

 

 

 

444,382

 

Senior secured credit facility

 

 

3.50

 

1,129

 

 

Asset-based borrowing facility(7)

 

18,400

 

2.80

 

1,680

 

31,789

 

Total credit facilities

 

18,400

 

 

 

 

 

31,789

 

Convertible senior notes

 

344,428

 

7.24

 

1,276

 

 

Junior subordinated notes

 

283,517

 

5.42

 

9,353

 

 

Total borrowings

 

$

6,658,230

 

 

 

 

 

$

7,112,051

 

 


(1)                                  Collateral for borrowings consists of securities available-for-sale, equity investments, at estimated fair value and corporate loans.

 

(2)                                  CLO 2007-1 junior secured notes consist of $55.7 million of mezzanine notes with a weighted average borrowing rate of 3.6% and $5.8 million of subordinated notes that do not have a contractual coupon rate, but instead receive a pro rata amount of the net distributions from CLO 2007-1.

 

(3)                                  CLO 2007-A junior secured notes consist of $6.2 million of mezzanine notes with a weighted average borrowing rate of 7.0% and $4.6 million of subordinated notes that do not have a contractual coupon rate, but instead receive a pro rata amount of the net distributions from CLO 2007-A.

 

(4)                                  The $125.8 million of CLO 2011-1 senior debt was used to finance commitments to purchase $67.6 million of corporate loans.

 

(5)                                  CLO 2007-1 junior secured notes to affiliates consist of $170.1 million of mezzanine notes with a weighted average borrowing rate of 5.2% and $130.3 million of subordinated notes that do not have a contractual coupon rate, but instead receive a pro rata amount of the net distributions from CLO 2007-1.

 

(6)                                  CLO 2007-A junior secured notes to affiliates consist of $55.0 million of mezzanine notes with a weighted average borrowing rate of 6.5% and $10.5 million of subordinated notes that do not have a contractual coupon rate, but instead receive a pro rata amount of the net distributions from CLO 2007-A.

 

(7)                                  Collateral for borrowings consists of oil and gas assets included in other assets in the condensed consolidated balance sheets at carrying amount.

 

21



Table of Contents

 

Certain information with respect to the Company’s borrowings as of December 31, 2010 is summarized in the following table (dollar amounts in thousands):

 

 

 

Outstanding
Borrowings

 

Weighted
Average
Borrowing
Rate

 

Weighted
Average
Remaining
Maturity
(in days)

 

Fair Value of
Collateral(1)

 

CLO 2005-1 senior secured notes

 

$

833,220

 

0.61

%

2,308

 

$

898,017

 

CLO 2005-2 senior secured notes

 

801,323

 

0.60

 

2,522

 

887,573

 

CLO 2006-1 senior secured notes

 

683,265

 

0.66

 

2,794

 

845,342

 

CLO 2007-1 senior secured notes

 

2,075,040

 

0.84

 

3,788

 

2,452,442

 

CLO 2007-1 junior secured notes(2)

 

61,504

 

 

3,788

 

72,689

 

CLO 2007-A senior secured notes

 

1,165,099

 

1.18

 

2,480

 

1,218,688

 

CLO 2007-A junior secured notes(3)

 

10,821

 

 

2,480

 

11,318

 

Total collateralized loan obligation secured debt

 

5,630,272

 

 

 

 

 

6,386,069

 

CLO 2007-1 junior secured notes to affiliates(4)

 

300,672

 

 

3,788

 

353,430

 

CLO 2007-A junior secured notes to affiliates(5)

 

65,452

 

 

2,480

 

68,462

 

Total collateralized loan obligation junior secured notes to affiliates

 

366,124

 

 

 

 

 

421,892

 

Senior secured credit facility

 

 

3.51

%

1,219

 

 

Asset-based borrowing facility(6)

 

18,400

 

2.76

 

1,770

 

32,760

 

Total credit facilities

 

18,400

 

 

 

 

 

32,760

 

Convertible senior notes

 

344,142

 

7.24

 

1,366

 

 

Junior subordinated notes

 

283,517

 

5.42

 

9,443

 

 

Total borrowings

 

$

6,642,455

 

 

 

 

 

$

6,840,721

 

 


(1)                                  Collateral for borrowings consists of securities available-for-sale, equity investments, at estimated fair value and corporate loans.

 

(2)                                  CLO 2007-1 junior secured notes consist of $55.7 million of mezzanine notes with a weighted average borrowing rate of 3.6% and $5.8 million of subordinated notes that do not have a contractual coupon rate, but instead receive a pro rata amount of the net distributions from CLO 2007-1.

 

(3)                                  CLO 2007-A junior secured notes consist of $6.2 million of mezzanine notes with a weighted average borrowing rate of 7.0% and $4.6 million of subordinated notes that do not have a contractual coupon rate, but instead receive a pro rata amount of the net distributions from CLO 2007-A.

 

(4)                                  CLO 2007-1 junior secured notes to affiliates consist of $170.4 million of mezzanine notes with a weighted average borrowing rate of 5.1% and $130.3 million of subordinated notes that do not have a contractual coupon rate, but instead receive a pro rata amount of the net distributions from CLO 2007-1.

 

(5)                              CLO 2007-A junior secured notes to affiliates consist of $55.0 million of mezzanine notes with a weighted average borrowing rate of 6.4% and $10.5 million of subordinated notes that do not have a contractual coupon rate, but instead receive a pro rata amount of the net distributions from CLO 2007-A.

 

(6)                                  Collateral for borrowings consists of oil and gas assets purchased during the fourth quarter of 2010 for an aggregate purchase price of $32.8 million, whereby no impairment was deemed to exist. These oil and gas assets are included in other assets in the condensed consolidated balance sheets.

 

CLO Debt

 

On March 31, 2011, the Company closed CLO 2011-1, a $400.0 million secured financing transaction secured by the assets held in CLO 2011-1. At closing, the Company entered into a senior loan agreement (the “CLO 2011-1 Agreement”) through which CLO 2011-1 is able to borrow up to $300.0 million through a non-recourse loan secured by the assets held in CLO 2011-1. The CLO 2011-1 senior loan matures on April 2, 2018 and borrowings under the CLO 2011-1 Agreement bear interest at a rate of three-month LIBOR plus 1.35%.  As of March 31, 2011, the Company had $125.8 million of borrowings outstanding under the CLO 2011-1 Agreement.

 

22


 


Table of Contents

 

The indentures governing the Company’s CLO transactions stipulate the reinvestment period during which the collateral manager, which is an affiliate of the Company’s Manager, can generally sell or buy assets at its discretion and can reinvest principal proceeds into new assets. As CLO 2007-A ended its reinvestment period during the fourth quarter of 2010, $110.4 million of proceeds were used to pay down original CLO 2007-A senior notes during the three months ended March 31, 2011. CLO 2005-1 ended its reinvestment period during April 2011 and CLO 2005-2, CLO 2006-1 and CLO 2007-1 will end their respective reinvestment periods during May 2011, August 2012 and May 2014, respectively. CLO 2011-1 does not have a reinvestment period and immediately starts amortizing once the planned holdings in CLO 2011-1 have been acquired.

 

During the first quarter of 2010, in an open market auction, the Company purchased $10.3 million of mezzanine notes issued by CLO 2007-A for $5.5 million and $72.7 million of mezzanine and subordinate notes issued by CLO 2007-1 for $38.8 million, both of which were previously held by an affiliate of the Manager. These transactions resulted in the Company recording an aggregate gain on extinguishment of debt totaling $38.7 million during the three months ended March 31, 2010.

 

Credit Facilities

 

Senior Secured Credit Facility

 

On May 3, 2010, the Company entered into a credit agreement for a four-year $210.0 million asset-based revolving credit facility (the “2014 Facility”), maturing on May 3, 2014, that is subject to, among other things, the terms of a borrowing base derived from the value of eligible specified financial assets. The borrowing base is subject to certain caps and concentration limits customary for financings of this type. The Company may obtain additional commitments under the 2014 Facility so long as the aggregate amount of commitments at any time does not exceed $600.0 million. On May 5, 2010, the Company obtained additional commitments of $40.0 million, bringing the total amount of commitments under the 2014 Facility to $250.0 million.

 

The Company has the right to prepay loans under the 2014 Facility in whole or in part at any time. Loans under the 2014 Facility bear interest at a rate equal to the London interbank offered rate (“LIBOR”) plus 3.25% per annum. The 2014 Facility contains customary covenants applicable to the Company, including a restriction from making distributions to holders of common shares in excess of 65% of the Company’s estimated annual taxable income.

 

As of March 31, 2011, the Company had no borrowings outstanding under the 2014 Facility.

 

Asset-Based Borrowing Facility

 

On November 5, 2010, the Company entered into a credit agreement for a five-year $49.7 million non-recourse, asset-based revolving credit facility (the “2015 Natural Resources Facility”), maturing on November 5, 2015, that is subject to, among other things, the terms of a borrowing base derived from the value of eligible specified oil and gas assets. The borrowing base is subject to certain caps and concentration limits customary for financings of this type. The Company has the right to prepay loans under the 2015 Natural Resources Facility in whole or in part at any time. Loans under the 2015 Natural Resources Facility bear interest at a rate equal to LIBOR plus a tiered applicable margin ranging from 1.75% to 2.75% per annum. The 2015 Natural Resources Facility contains customary covenants applicable to the Company.

 

As of March 31, 2011, the Company had $18.4 million of borrowings outstanding under the 2015 Natural Resources Facility. In addition, under the 2015 Natural Resources Facility, the Company had a letter of credit outstanding totaling $1.0 million.

 

As of March 31, 2011, the Company believes it was in compliance with the covenant requirements for both credit facilities.

 

Convertible Debt

 

During the first quarter of 2010, the Company repurchased $95.2 million par amount of its 7.0% Notes, reducing the amount outstanding from $275.8 million as of December 31, 2009 to $180.6 million as of December 31, 2010. These transactions resulted in the Company recording a gain of $1.3 million, which was partially offset by a write-off of $0.6 million of unamortized debt issuance costs during 2010.

 

On January 15, 2010, the Company issued $172.5 million of 7.5% convertible senior notes due January 15, 2017 (“7.5% Notes”). The 7.5% Notes bear interest at a rate of 7.5% per annum on the principal amount, accruing from

 

23



Table of Contents

 

January 15, 2010. Interest is payable semiannually in arrears on January 15 and July 15 of each year, beginning on July 15, 2010. The 7.5% Notes will mature on January 15, 2017 unless previously redeemed, repurchased or converted in accordance with their terms prior to such date. Holders of the 7.5% Notes may convert their notes at the applicable conversion rate at any time prior to the close of business on the business day immediately preceding the stated maturity date subject to the Company’s right to terminate the conversion rights of the notes. The Company may satisfy its obligation with respect to the 7.5% Notes tendered for conversion by delivering to the holder either cash, common shares, no par value, issued by the Company or a combination thereof. The initial conversion rate for each $1,000 principal amount of 7.5% Notes was 122.2046 common shares, which is equivalent to an initial conversion price of approximately $8.18 per share. The conversion rate is adjusted under certain circumstances, including the occurrence of certain fundamental change transactions and the payment of a quarterly cash distribution in excess of $0.05 per share, but will not be adjusted for accrued and unpaid interest on the 7.5% Notes. As of March 31, 2011, the conversation rate for each $1,000 principal amount of 7.5% Notes was 126.8568 common shares.

 

In accordance with accounting for convertible debt instruments that may be settled in cash upon conversion, the Company separately accounted for the liability and equity components to reflect the nonconvertible debt borrowing rate. The Company determined that the equity component of the 7.5% Notes totaled $10.0 million and is included in paid-in-capital on the Company’s condensed consolidated balance sheet as of March 31, 2011 and December 31, 2010. The remaining liability component of $163.9 million and $163.6 million as of March 31, 2011 and December 31, 2010, respectively, is included within convertible senior notes on the Company’s condensed consolidated balance sheet as of March 31, 2011 and December 31, 2010, is comprised of the principal $172.5 million less the unamortized debt discount of $8.6 million and $8.9 million, respectively. The total debt discount amortization recognized for the three months ended March 31, 2011 and 2010 was $0.3 million and $0.2 million, respectively. The debt discount will continue to be amortized at the effective interest rate of 8.6%. For the three months ended March 31, 2011 and 2010, the total interest expense recognized on the 7.5% Notes was $3.2 million and $2.7 million, respectively.

 

Note 8. Derivative Financial Instruments

 

The Company enters into derivative transactions in order to hedge its interest rate risk exposure to the effects of interest rate changes. Additionally, the Company enters into derivative transactions in the course of its portfolio management activities. The counterparties to the Company’s derivative agreements are major financial institutions with which the Company and its affiliates may also have other financial relationships. In the event of nonperformance by the counterparties, the Company is potentially exposed to losses. The counterparties to the Company’s derivative agreements have investment grade ratings and, as a result, the Company does not anticipate that any of the counterparties will fail to fulfill their obligations.

 

24



Table of Contents

 

The table below summarizes the aggregate notional amount and estimated net fair value of the derivative instruments as of March 31, 2011 and December 31, 2010 (amounts in thousands):

 

 

 

As of
March 31, 2011

 

As of
December 31, 2010

 

 

 

Notional

 

Estimated
Fair Value

 

Notional

 

Estimated
Fair Value

 

Cash Flow Hedges:

 

 

 

 

 

 

 

 

 

Interest rate swaps

 

$

483,333

 

$

(50,176

)

$

483,333

 

$

(58,365

)

Free-Standing Derivatives:

 

 

 

 

 

 

 

 

 

Commodity swaps

 

 

(618

)

 

(226

)

Credit default swaps—protection sold

 

13,500

 

470

 

13,500

 

492

 

Total rate of return swaps

 

 

135

 

 

104

 

Foreign exchange forward contracts

 

(162,913

)

(23,267

)

(154,405

)

(17,296

)

Foreign exchange options

 

130,207

 

16,473

 

130,207

 

14,791

 

Common stock warrants

 

 

4,171

 

 

3,453

 

Total

 

$

464,127

 

$

(52,812

)

$

472,635

 

$

(57,047

)

 

Cash Flow Hedges

 

The Company uses interest rate derivatives consisting of swaps to hedge a portion of the interest rate risk associated with its borrowings under CLO senior secured notes as well as certain of its floating rate junior subordinated notes. The Company designates these financial instruments as cash flow hedges.

 

During June 2010, the Company entered into a $100.0 million notional pay-fixed, receive-variable interest rate swap. The swap has been designated as a cash flow hedge, the objective of which is to eliminate the variability of cash flows in the interest payments of the Company’s floating rate junior subordinated notes debt due to fluctuations in the indexed rate. Changes in value of the interest rate swap are recorded through other comprehensive income, with gains or losses representing hedge ineffectiveness, if any, recognized in earnings during the reporting period. The hedged transaction period is through October 2036, which is the stated maturity of the floating rate debt.

 

The following table shows the net gains (losses) recognized in other comprehensive income related to derivatives in cash flow hedging relationships for the three months ended March 31, 2011 and 2010 (amounts in thousands):

 

 

 

Three months ended
March 31, 2011

 

Three months ended
March 31, 2010

 

Gains (losses) recognized in other comprehensive income on cash flow hedges

 

$

8,192

 

$

(4,892

)

 

Free-Standing Derivatives

 

Free-standing derivatives are derivatives that the Company has entered into in conjunction with its investment and risk management activities, but for which the Company has not designated the derivative contract as a hedging instrument for accounting purposes. Such derivative contracts may include credit default swaps (“CDS”), foreign exchange contracts and options, interest rate swaps and commodity derivatives. Free-standing derivatives also include investment financing arrangements (total rate of return swaps) whereby the Company receives the sum of all interest, fees and any positive change in fair value amounts from a reference asset with a specified notional amount and pays interest on such notional amount plus any negative change in fair value amounts from such reference asset.

 

Gains and losses on free-standing derivatives are reported on the condensed consolidated statements of operations in net realized and unrealized gain (loss) on derivatives and foreign exchange. Unrealized gains (losses) represent the change in fair value of the derivative instruments and are noncash items.

 

Credit Default Swaps

 

A CDS is a contract in which the contract buyer pays, in the case of a short position, or receives, in the case of long position, a periodic premium until the contract expires or a credit event occurs. In return for this premium, the contract seller receives a payment from or makes a payment to the buyer if there is a credit default or other specified credit event with respect to the issuer (also known as the referenced entity) of the underlying credit instrument referenced in the CDS. Typical

 

25



Table of Contents

 

credit events include bankruptcy, dissolution or insolvency of the referenced entity, failure to pay and restructuring of the obligations of the referenced entity.

 

As of March 31, 2011 and December 31, 2010, the Company had sold protection with a notional amount of $13.5 million. The Company sells protection to replicate fixed income securities and to complement the spot market when cash securities of the referenced entity of a particular maturity are not available or when the derivative alternative is less expensive compared to other purchasing alternatives.

 

Commodity Derivatives

 

In an effort to minimize the effects of the volatility of oil and natural gas prices, the Company will from time to time, enter into derivative instruments such as swap contracts to hedge its forecasted oil and natural gas sales. The Company does not designate these contracts as cash flow hedges and as such, the changes in fair value of these instruments are recorded in current period earnings.

 

During December 2010, the Company entered into commodity derivative contracts, consisting of oil and natural gas receive-fixed, pay-floating swaps for certain years through 2013. For the three months ended March 31, 2011, the Company had an immaterial amount of oil and natural gas derivatives settlements. The oil and natural gas derivatives are settled monthly.

 

For all hedges where hedge accounting is being applied, effectiveness testing and other procedures to ensure the ongoing validity of the hedges are performed at least quarterly. During the three months ended March 31, 2011 and 2010, the Company recognized an immaterial amount of ineffectiveness in income on the condensed consolidated statements of operations from its cash flow and fair value hedges.

 

Note 9. Accumulated Other Comprehensive Income

 

The components of accumulated other comprehensive income were as follows (amounts in thousands):

 

 

 

As of
March 31, 2011

 

As of
December 31, 2010

 

Net unrealized gains on available-for-sale securities

 

$

202,043

 

$

189,139

 

Net unrealized losses on cash flow hedges

 

(47,351

)

(55,543

)

Accumulated other comprehensive income

 

$

154,692

 

$

133,596

 

 

The components of changes in other comprehensive income were as follows (amounts in thousands):

 

 

 

Three months ended
March 31, 2011

 

Three months ended
March 31, 2010

 

Unrealized gains on securities available-for-sale:

 

 

 

 

 

Unrealized gains arising during period

 

$

20,240

 

$

30,107

 

Reclassification adjustments for (gains) losses realized in net income(1)

 

(7,336

)

(7,530

)

Unrealized gains on securities available-for-sale

 

12,904

 

22,577

 

Unrealized gains (losses) on cash flow hedges

 

8,192

 

(4,892

)

Other comprehensive income

 

$

21,096

 

$

17,685

 

 


(1)                                  Excludes an impairment charge of nil and $1.1 million for investments which were determined to be other-than-temporary for the three months ended March 31, 2011 and 2010 respectively.

 

Note 10. Commitments & Contingencies

 

Commitments

 

As part of its strategy of investing in corporate loans, the Company commits to purchase interests in primary market loan syndications, which obligate the Company to acquire a predetermined interest in such loans at a specified price on a to-be-determined settlement date. Consistent with standard industry practices, once the Company has been informed of the

 

26



Table of Contents

 

amount of its syndication allocation in a particular loan by the syndication agent, the Company bears the risks and benefits of changes in the fair value of the syndicated loan from that date forward. In addition, the Company also commits to purchase corporate loans in the secondary market that similar to the above, the Company bears the risks and benefits of changes in the fair value from the trade date forward. As of March 31, 2011 and December 31, 2010, the Company had committed to purchase corporate loans with aggregate commitments totaling $192.4 million and $90.9 million, respectively. In addition, the Company participates in certain contingent financing arrangements, whereby the Company is committed to provide funding of up to a specific amount at the discretion of the borrower. As of March 31, 2011 and December 31, 2010, the Company had unfunded financing commitments for corporate loans totaling $33.1 million and $31.6 million, respectively. In addition, as of March 31, 2011 and December 31, 2010, the Company had unfunded financing commitments for private equity investments totaling $10.4 million and $13.1 million, respectively. The Company did not have any material losses as of March 31, 2011, nor does it expect material losses related to those corporate loans and private equity investments for which it committed to purchase and fund.

 

Contingencies

 

The Company has been named as a party in various legal actions which include the matters described below. It is inherently difficult to predict the ultimate outcome, particularly in cases in which claimants seek substantial or unspecified damages, or where investigations or proceedings are at an early stage and the Company cannot predict with certainty the loss or range of loss that may be incurred. The Company has denied, or believes it has a meritorious defense and will deny liability in the significant cases pending against the Company discussed below. Based on current discussion and consultation with counsel, management believes that the resolution of these matters will not have a material impact on the Company’s consolidated financial statements.

 

On July 10, 2009, the Company surrendered for cancellation, without consideration, approximately $64.0 million of mezzanine notes issued to the Company by CLO 2005-2 (the “2005-2 Notes”) and approximately $222.4 million of mezzanine and junior notes issued to the Company by CLO 2006-1 (the “2006-1 Notes”), as well as certain other notes issued to the Company by another CLO. The surrendered notes were cancelled by the trustee under the applicable indenture, and the obligations due under such surrendered notes were deemed extinguished.

 

During 2010, certain holders of the senior notes of CLO 2006-1 (the “2006-1 Noteholders”) notified the related trustee of purported defaults under the indenture related to the surrender of the 2006-1 Notes. The Company does not believe based on discussions with counsel that an event of default has occurred and is engaged in discussions with the 2006-1 Noteholders to resolve this matter. Accordingly, the Company does not believe that this matter will have a material effect on its financial condition.

 

Note 11. Common Shares, Restricted Shares and Share Options

 

On May 4, 2007, the Company adopted an amended and restated share incentive plan (the “2007 Share Incentive Plan”) that provides for the grant of qualified incentive common share options that meet the requirements of Section 422 of the Code, non-qualified common share options, share appreciation rights, restricted common shares and other share-based awards. The Compensation Committee of the board of directors administers the plan. Share options and other share-based awards may be granted to the Manager, directors, officers and any key employees of the Manager and to any other individual or entity performing services for the Company.

 

The exercise price for any share option granted under the 2007 Share Incentive Plan may not be less than 100% of the fair market value of the common shares at the time the common share option is granted. Each option to acquire a common share must terminate no more than ten years from the date it is granted. As of March 31, 2011, the 2007 Share Incentive Plan authorizes a total of 8,589,625 shares that may be used to satisfy awards under the 2007 Share Incentive Plan. On January 21, 2011, the Compensation Committee of the board of directors granted the Manager 240,845 restricted common shares subject to graded vesting over four years with the final vesting date of March 1, 2015.

 

The following table summarizes restricted common share transactions:

 

 

 

Manager

 

Directors

 

Total

 

Unvested shares as of January 1, 2011

 

1,097,000

 

212,604

 

1,309,604

 

Issued

 

240,845

 

 

240,845

 

Vested

 

(1,097,000

)

 

(1,097,000

)

Forfeited

 

 

 

 

Unvested shares as of March 31, 2011

 

240,845

 

212,604

 

453,449

 

 

27



Table of Contents

 

The Company is required to value any unvested restricted common shares granted to the Manager at the current market price. The Company valued the unvested restricted common shares granted to the Manager at $9.79 and $8.21 per share at March 31, 2011 and 2010, respectively. There were $2.9 million and $3.3 million of total unrecognized compensation costs related to unvested restricted common shares granted as of March 31, 2011 and 2010, respectively. These costs are expected to be recognized over the next four years. The following table summarizes common share option transactions:

 

 

 

Number of
Options

 

Weighted Average
Exercise Price

 

Outstanding as of January 1, 2011

 

1,932,279

 

$

20.00

 

Granted

 

 

 

Exercised

 

 

 

Forfeited

 

 

 

Outstanding as of March 31, 2011

 

1,932,279

 

$

20.00

 

 

As of March 31, 2011 and 2010, 1,932,279 common share options were exercisable. As of March 31, 2011, the common share options were fully vested and expire in August 2014. For the three months ended March 31, 2011 and 2010, the components of share-based compensation expense are as follows (amounts in thousands):

 

 

 

For the three
months ended
March 31, 2011

 

For the three
months ended
March 31, 2010

 

Restricted shares granted to Manager

 

$

1,634

 

$

2,392

 

Restricted shares granted to certain directors

 

199

 

502

 

Total share-based compensation expense

 

$

1,833

 

$

2,894

 

 

Note 12. Management Agreement and Related Party Transactions

 

The Manager manages the Company’s day-to-day operations, subject to the direction and oversight of the Company’s board of directors. The Management Agreement expires on December 31 of each year, but is automatically renewed for a one-year term each December 31 unless terminated upon the affirmative vote of at least two-thirds of the Company’s independent directors, or by a vote of the holders of a majority of the Company’s outstanding common shares, based upon (1) unsatisfactory performance by the Manager that is materially detrimental to the Company or (2) a determination that the management fee payable by the Manager is not fair, subject to the Manager’s right to prevent such a termination under this clause (2) by accepting a mutually acceptable reduction of management fees. The Manager must be provided 180 days prior notice of any such termination and will be paid a termination fee equal to four times the sum of the average annual base management fee and the average annual incentive fee for the two 12-month periods immediately preceding the date of termination, calculated as of the end of the most recently completed fiscal quarter prior to the date of termination.

 

The Management Agreement contains certain provisions requiring the Company to indemnify the Manager with respect to all losses or damages arising from acts not constituting bad faith, willful misconduct, or gross negligence. The Company has evaluated the impact of these guarantees on its condensed consolidated financial statements and determined that they are not material.

 

Base Management Fees and Manager Share-Based Compensation

 

For the three months ended March 31, 2011, the Company incurred $6.2 million in base management fees. As of March 31, 2011, the Company had $2.1 million base management fee payable to the Manager. In addition, the Company recognized share-based compensation expense related to restricted common shares granted to the Manager of $1.6 million for the three months ended March 31, 2011 (see Note 11). For the three months ended March 31, 2010, the Company incurred $4.2 million in base management fees. In addition, the Company recognized share-based compensation expense related to restricted common shares granted to the Manager of $2.4 million for the three months ended March 31, 2010 (see Note 11).

 

Base management fees incurred and share-based compensation expense relating to restricted common shares granted to the Manager are included in related party management compensation on the condensed consolidated statements of

 

28



Table of Contents

 

operations. Expenses incurred by the Manager and reimbursed by the Company are reflected in the respective condensed consolidated statements of operations, non-investment expense category based on the nature of the expense.

 

The Manager is waiving base management fees related to the $230.4 million common share offering and $270.0 million common share rights offering that occurred during the third quarter of 2007 until such time as the Company’s common share closing price on the NYSE is $20.00 or more for five consecutive trading days. Accordingly, the Manager permanently waived approximately $2.2 million of base management fees during each of the three months ended March 31, 2011 and 2010.

 

Incentive Fees

 

During the three months ended March 31, 2011, the Manager earned $12.0 million of incentive fees. As of March 31, 2011, the Company had $12.0 million incentive fee payable to the Manager. During the three months ended March 31, 2010, the Manager earned $22.2 million of incentive fees. Of this amount, the Manager permanently waived payment of $9.7 million of incentive fees that were related to the $38.7 million gain recorded by the Company as a result of the repurchase of $83.0 million of mezzanine and subordinate notes issued by CLO 2007-1 and CLO 2007-A during the quarter ended March 31, 2010. Incentive fees are included in related party management compensation on the Company’s condensed consolidated statement of operations.

 

CLO Management Fees

 

An affiliate of the Manager entered into separate management agreements with the respective investment vehicles for CLO 2005-1, CLO 2005-2, CLO 2006-1, CLO 2007-1, CLO 2007-A, CLO 2009-1 and CLO 2011-1 and is entitled to receive fees for the services performed as collateral manager for all of these CLOs, except for CLO 2011-1. The collateral manager has the option to waive the fees it earns for providing management services for the CLO.

 

During the three months ended March 31, 2010, the collateral manager began waiving the management fees for all CLOs, except for CLO 2005-1, and waived aggregate CLO management fees of $4.5 million. During the three months ended March 31, 2011, the collateral manager waived all management fees for all CLOs, except for CLO 2005-1, and waived aggregate CLO management fees of $8.8 million. For the three months ended March 31, 2011 and 2010, the Company recorded an expense for CLO management fees totaling $1.3 million and $1.4 million, respectively.

 

Reimbursable General and Administrative Expenses

 

Beginning January 2009, the Manager permanently waived reimbursable general and administrative expenses allocable to the Company in an amount equal to the incremental CLO management fees received by the Manager. For the three months ended March 31, 2010, the Manager permanently waived reimbursement of allocable general and administrative expenses totaling $1.3 million. Due to the reinstatement of waived CLO management fees described above, effective June 2010, all incremental CLO management fees received by the Manager had been fully applied to offset these reimbursable expenses. Accordingly, for the three months ended March 31, 2011, there were no reimbursable general and administrative expenses waived by the Manager; rather, the Company incurred reimbursable general and administrative expenses to its Manager of $1.7 million, as compared to nil for the three months ended March 31, 2010.

 

Affiliated Investments

 

The Company has invested in corporate loans, debt securities, and other investments of entities that are affiliates of KKR. As of March 31, 2011, the aggregate par amount of these affiliated investments totaled $2.6 billion, or approximately 32% of the total investment portfolio, and consisted of 29 issuers. The total $2.6 billion in affiliated investments was comprised of $2.2 billion of corporate loans, $307.9 million of corporate debt securities available-for-sale and $52.9 million of equity investments, at estimated fair value. As of December 31, 2010, the aggregate par amount of these affiliated investments totaled $2.4 billion, or approximately 30% of the total investment portfolio, and consisted of 27 issuers. The total $2.4 billion in affiliated investments was comprised of $2.1 billion of corporate loans, $314.2 million of corporate debt securities available-for-sale and $25.6 million of equity investments, at estimated fair value.

 

29



Table of Contents

 

Note 13. Fair Value of Financial Instruments

 

Fair Value of Financial Instruments

 

The fair value of certain instruments including securities available-for-sale, corporate loans, derivatives, and loan commitments is based on quoted market prices or estimates provided by independent pricing sources. The fair value of cash and cash equivalents, interest receivable, and interest payable approximates cost due to the short-term nature of these instruments.

 

The table below discloses the carrying value and the estimated fair value of the Company’s financial instruments as of March 31, 2011 and December 31, 2010 (amounts in thousands):

 

 

 

As of March 31, 2011

 

As of December 31, 2010

 

 

 

Carrying
Amount

 

Estimated Fair
Value

 

Carrying
Amount

 

Estimated Fair
Value

 

Financial Assets:

 

 

 

 

 

 

 

 

 

Cash, restricted cash, and cash equivalents

 

$

720,912

 

$

720,912

 

$

885,254

 

$

885,254

 

Securities available-for-sale

 

846,676

 

846,676

 

838,894

 

838,894

 

Corporate loans, net of allowance for loan losses of $198,582 and $209,030 as of March 31, 2011 and December 31, 2010 respectively

 

5,632,057

 

5,857,755

 

5,857,816

 

6,060,530

 

Corporate loans held for sale

 

869,808

 

1,006,727

 

463,628

 

473,681

 

Residential mortgage-backed securities

 

90,369

 

90,369

 

93,929

 

93,929

 

Equity investments, at estimated fair value

 

147,462

 

147,462

 

99,955

 

99,955

 

Interest and principal receivable

 

45,898

 

45,898

 

57,414

 

57,414

 

Derivative assets

 

23,921

 

23,921

 

19,519

 

19,519

 

Private equity investments, at cost(1)

 

3,825

 

4,635

 

4,800

 

5,051

 

Financial Liabilities:

 

 

 

 

 

 

 

 

 

Collateralized loan obligation secured debt

 

$

5,646,037

 

$

5,267,654

 

$

5,630,272

 

$

5,176,052

 

Collateralized loan obligation junior secured notes to affiliates

 

365,848

 

268,003

 

366,124

 

254,522

 

Credit facilities

 

18,400

 

18,400

 

18,400

 

18,400

 

Convertible senior notes

 

344,428

 

431,025

 

344,142

 

425,564

 

Junior subordinated notes

 

283,517

 

266,506

 

283,517

 

264,025

 

Accounts payable, accrued expenses and other liabilities

 

22,337